Triple-negative breast cancer (TNBC) is characterized by the absence of ER, PR, and HER2 expression and is considered the most aggressive and malignant subtype of breast cancer 3, accounting for approximately 15%-25% of all invasive breast cancers 4. This evidence concerns the gene ERBB2 and breast carcinoma.